Aixtron’s 34% Monthly Pullback Prompts Analyst Upgrade as Order Momentum and Institutional Holdings Grow

Aixtron shares plunge 34% in a month, triggering MWB upgrade to Hold. Analysts remain divided with targets from €39 to €70. Oversold RSI and institutional buying signal potential stabilization.

The dramatic sell-off in Aixtron shares over the past month has forced a change of stance from at least one research house, even as the wider analyst community remains deeply split on the stock’s prospects. MWB Research lifted its rating on the Aachen-based semiconductor equipment maker from “Sell” to “Hold” on 20 July, citing the roughly 34% correction in the preceding 30 trading days. The upgrade signals that the valuation has returned to what the analysts consider fair territory, rather than a bullish call — the new price target sits at €40, barely above the current share price of around €39. Notably, the 14-day relative strength index has dropped to 33.6, indicating an oversold condition that suggests selling momentum may be exhausted.

But the broader analyst consensus is far from uniform. While MWB moved to neutral, Barclays reaffirmed a €39 price target in a sector note on 19 July, effectively endorsing current levels. At the other end of the spectrum, JPMorgan held firm with an “Overweight” rating and a €70 target on 14 July, pointing to robust demand in optoelectronics. That nearly €31 gap between the highest and lowest targets underscores the uncertainty surrounding Aixtron’s near-term trajectory after a share price that, despite the correction, remains up more than 125% year to date.

Behind the slide lies a cocktail of profit-taking in artificial-intelligence-related equities and weakness in the Asian chip market. Aixtron’s stock hit a 52-week high of €62.68 on 18 June, only to shed roughly 37% by 16 July. The stock now trades about 25% below its 50-day moving average of €51.98. Yet the sell-off has done little to deter institutional investors. Goldman Sachs crossed a notification threshold on 10 July, reporting a total stake of 8.69% of voting rights — comprising 3.34% held directly and the remainder via financial instruments — signaling continued conviction among large asset managers.

On the operational front, Aixtron has continued to rack up specific orders that support the narrative of intact demand for compound semiconductor deposition equipment. The MIT Lincoln Laboratory ordered two 300-mm Hyperion systems on 23 June for research into gallium nitride and 2D materials. Earlier, on 8 June, Japanese chipmaker ROHM Semiconductor selected Aixtron’s G10-GaN platform to expand its GaN power device output. These deals, together with the company’s expectation of new bookings exceeding €200 million in the second quarter, paint a picture of sustained commercial traction even as the share price wobbles.

Financially, Aixtron strengthened its balance sheet in the spring, placing a €450 million convertible bond in mid-April. Shortly afterward, management raised its full-year 2026 guidance, now targeting revenue of €530–590 million with an EBIT margin of 17–20%. The annual general meeting in May approved a dividend of €0.15 per share for fiscal 2025. All eyes now turn to the half-year report due on 30 July, which will test whether the company’s operational strength can hold up against a broader sector backdrop that has been rattled by volatility in memory-chip names and shifting sentiment around AI valuations.